<?xml version="1.0" encoding="UTF-8"?>
<p>In the present review, 15 
 <italic>in vitro</italic> studies were included. They were from Korea (9/15), Taiwan (3/15), China (2/15), and Iran (1/15). Most of the studies (10/15) were published between 2011 and 2018 whereas only two studies (
 <xref rid="B72" ref-type="bibr">Runfeng et al., 2020</xref>; 
 <xref rid="B35" ref-type="bibr">Jo et al., 2020</xref>) were published in 2020 and one study (
 <xref rid="B90" ref-type="bibr">Weng et al., 2019</xref>) in 2019. Of them, only one study (
 <xref rid="B72" ref-type="bibr">Runfeng et al., 2020</xref>) investigated the antiviral activity against SARS-CoV-2, and another (
 <xref rid="B90" ref-type="bibr">Weng et al., 2019</xref>) on the human coronavirus NL63, whereas the other studies were not cell-based. Three studies used plant extracts and one study (
 <xref rid="B72" ref-type="bibr">Runfeng et al., 2020</xref>), a herbal mixture of 11 Chinese plants. Ethanol, methanol, and water were the solvents used to prepare the plant extracts included in these studies. Most of the studies were conducted with isolated natural compounds belonging to different phytochemical classes. Phenolic compounds were the most frequently reported.
</p>
